BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8850268)

  • 1. Etiologic value of p53 mutation spectra and differences with histology in lung cancers.
    Shimmyo T; Okada A; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Osada H; Tsuchiya E
    Cancer Sci; 2008 Feb; 99(2):287-95. PubMed ID: 18271927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking, p53 mutation, and lung cancer.
    Gibbons DL; Byers LA; Kurie JM
    Mol Cancer Res; 2014 Jan; 12(1):3-13. PubMed ID: 24442106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous double primary lung cancers via p53 pathway induced by heavy smoking.
    Lin CC; Chian CF; Perng WC; Cheng MF
    Ann Saudi Med; 2010; 30(3):236-8. PubMed ID: 20427942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical models of tissue stem and transit target cell divisions and the risk of radiation- or smoking-associated cancer.
    Little MP; Hendry JH
    PLoS Comput Biol; 2017 Feb; 13(2):e1005391. PubMed ID: 28196079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the silent threat: Exploring the cascade of -radiation-induced damage culminating in cancer.
    Sharma A; Chatterjee D; Vinay K
    Indian J Dermatol Venereol Leprol; 2023 Oct; ():1-3. PubMed ID: 38031694
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study.
    Boldrin E; Rumiato E; Fassan M; Cappellesso R; Rugge M; Chiarion-Sileni V; Ruol A; Alfieri R; Cagol M; Castoro C; Amadori A; Saggioro D
    PLoS One; 2015; 10(1):e0117070. PubMed ID: 25611972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.
    Sun Y; Myers CJ; Dicker AP; Lu B
    PLoS One; 2014; 9(2):e87492. PubMed ID: 24558369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3.
    Aziz MH; Shen H; Maki CG
    Oncogene; 2011 Nov; 30(46):4678-86. PubMed ID: 21643018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second neoplasms in patients with chronic lymphocytic leukemia.
    Wiernik PH
    Curr Treat Options Oncol; 2004 Jun; 5(3):215-23. PubMed ID: 15115650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TP53 gene, tobacco exposure, and lung cancer.
    Toyooka S; Tsuda T; Gazdar AF
    Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 12. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
    De Benedetti VM; Travis LB; Welsh JA; van Leeuwen FE; Stovall M; Clarke EA; Boice JD; Bennett WP
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):93-8. PubMed ID: 8850268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.